Limited-Time Offer: Enjoy 60% Savings! - Ends In 0d 00h 00m 00s Coupon code: 60OFF
Welcome to QA4Exam
Logo

- Trusted Worldwide Questions & Answers

Most Recent NABP NAPLEX Exam Questions & Answers


Prepare for the NABP North American Pharmacist Licensure Examination exam with our extensive collection of questions and answers. These practice Q&A are updated according to the latest syllabus, providing you with the tools needed to review and test your knowledge.

QA4Exam focus on the latest syllabus and exam objectives, our practice Q&A are designed to help you identify key topics and solidify your understanding. By focusing on the core curriculum, These Questions & Answers helps you cover all the essential topics, ensuring you're well-prepared for every section of the exam. Each question comes with a detailed explanation, offering valuable insights and helping you to learn from your mistakes. Whether you're looking to assess your progress or dive deeper into complex topics, our updated Q&A will provide the support you need to confidently approach the NABP NAPLEX exam and achieve success.

The questions for NAPLEX were last updated on Jan 19, 2025.
  • Viewing page 1 out of 31 pages.
  • Viewing questions 1-5 out of 155 questions
Get All 155 Questions & Answers
Question No. 1

Which of the following is/are appropriate for pseudomonas skin/soft tissue infections?

Show Answer Hide Answer
Correct Answer: B

Ceftaroline covers MRSA, but it does not cover pseudomonas. Ertapenem does not cover pseudomonas. Cefazolin does not cover MRSA nor Pseudomonas. Cefepime has pseudomonas coverage. Vancomycin does not cover gram negative bacteria.


Question No. 2

What is the standard oral weekly dose of alendronate given to treat osteoporosis?

Show Answer Hide Answer
Correct Answer: B

The standard oral dose of alendronate in the treatment of osteoporosis is 70mg weekly -- or 10mg per day.


Question No. 3

A patient who weighs 80kg is ordered Esmolol at 50mcg/kg/min. Esmolol comes in 2500mg/250 ml NS premixed bags. What is the infusion rate in mls/hr?

Show Answer Hide Answer
Correct Answer: D

50 mcg/kg/min 80 kg = 4 mg/min 60 min/hr = 240 mg/hr 2500 mg / 250 mL = 10 mg/mL 240 mg/hr / 10 mg/ mL = 24 mL/hr Esmolol Infusion


Question No. 4

How many millimoles of sodium are in 0.9% sodium chloride?

Show Answer Hide Answer
Correct Answer: D

0.9% = 9 grams per every 1,000mL Molecular weight of NaCl = 58.5 9 / 58.5 = 0.154 moles 0.154 moles is the same as 154 millimoles There are 154 millimoles of sodium ions and 154 millimoles of chloride ions in 0.9% sodium chloride.


Question No. 5

Select the class of Anti-diabetic medication that works in the specified organ to prevent hyperglycemi

a. Select all that applies. Liver (D)

Show Answer Hide Answer
Correct Answer: C

DPP4 Inhibitors, (D)Glucagon-like peptide-1 receptor agonists, (E)Thiazolidinediones (F)Biguanide Sulfonylureas work in beta cells in the pancreas that are still functioning to enhance insulin secretion. Alpha- Glucosidase Inhibitors stop -glucosidase enzymes in the small intestine and delay digestion and absorption of starch and disaccharides which lowers the levels of glucose after meals. DPP4 blocks the degradation ofGLP-1, GIP, and a variety of other peptides, including brain natriuretic peptide. Glucagon-like peptide-1 receptor agonists work in various organs of the body. Glucagon-like peptide-1 receptor agonists enhance glucose homeostasis through: (i) stimulation of insulin secretion; (ii) inhibition of glucagon secretion; (iii) direct and indirect suppression of endogenous glucose production; (iv) suppression of appetite; (v) enhanced insulin sensitivity secondary to weight loss; (vi) delayed gastric emptying, resulting in decreased postprandial hyperglycaemia. Thiazolidinediones are the only true insulin-sensitising agents, exerting their effects in skeletal and cardiac muscle, liver, and adipose tissue. It ameliorates insulin resistance, decreases visceral fat.

Biguanides work in liver, muscle, adipose tissue via activation of AMP-activated protein kinase (AMPK) reduce hepatic glucose production. SGLT2 inhibitors work in the kidneys to inhibit sodium-glucose transport proteins to reabsorb glucose into the blood from muscle cells; overall this helps to improve insulin release from the beta cells of the pancreas.


https://doi.org/10.1093/eurheartj/ehv239

Unlock All Questions for NABP NAPLEX Exam

Full Exam Access, Actual Exam Questions, Validated Answers, Anytime Anywhere, No Download Limits, No Practice Limits

Get All 155 Questions & Answers